Jospeh P McGuirk

63PUBLICATIONS
361CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Jun 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis.

|Jun 03, 2026
Real-world treatment patterns of patients with large B-cell lymphoma over time and into a post-CAR T approval era.

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Apr 06, 2026
Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Sigrun Einarsdottir, Teng Fei, Katina H Singh

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Nov 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

Pageof 11

Frequent Collaborators

12 joint publications

Miguel-Angel Perales

11 joint publications

James A Davis

11 joint publications

Nausheen Ahmed

10 joint publications

Surbhi Sidana